GD
39
-2
FFIV
62
-4
VZ
22
-3
DHI
33
-2
KMX
42
-7
CMCSA
35
8
ZBH
71
6
AON
34
-2
RRC
60
2
ACN
50
-6
NFLX
55
-4
VFC
65
11
HCA
37
-11
STT
42
-17
PPL
44
-5
PX
50
-9
HES
62
3
ED
42
-3
MMM
44
-3
STZ
18
-12
GD
39
-2
FFIV
62
-4
VZ
22
-3
DHI
33
-2
KMX
42
-7
CMCSA
35
8
ZBH
71
6
AON
34
-2
RRC
60
2
ACN
50
-6
NFLX
55
-4
VFC
65
11
HCA
37
-11
STT
42
-17
PPL
44
-5
PX
50
-9
HES
62
3
ED
42
-3
MMM
44
-3
STZ
18
-12
Financhill
Back

Heidrick & Struggles International Vs. Intra-Cellular Therapies Industry Stock Comparison

Sell
37

HSII
Heidrick & Struggles International

Last Price:
$43.82
Seasonality Move:
1.36%
Sell
42

ITCI
Intra-Cellular Therapies

Last Price:
$94.86
Seasonality Move:
2.9%
Sell
37
Heidrick & Struggles International (HSII) is a Sell

Is Heidrick & Struggles International a Buy, Sell or Hold?

  • The current Heidrick & Struggles International [HSII] share price is $43.80. The Score for HSII is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • HSII is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $94.87. The Score for ITCI is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HSII Stock Price Chart

What is Heidrick & Struggles International's stock price today?

  • The Heidrick & Struggles International share price today is $43.80
    The current trend is moderately bearish and HSII is experiencing buying pressure, which is a positive indicator for future bullish movement.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $94.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight buying pressure.

HSII Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.2 Sell
Relative Strength Index (14 RSI): 43.33 Sell
Chaikin Money Flow: 113040 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.01 - 45.39) Sell
Bollinger Bands (100): (37.32 - 45.14) Buy

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.52 Buy
Relative Strength Index (14 RSI): 71.02 Buy
Chaikin Money Flow: 1717350 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (82.26 - 87.1) Buy
Bollinger Bands (100): (74.04 - 85.96) Buy

HSII Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.15 Sell
20-day SMA: 44.54 Sell
50-day SMA: 44.79 Sell
200-day SMA: 37.3 Buy
8-day EMA: 44.13 Sell
20-day EMA: 44.44 Sell
50-day EMA: 43.79 Buy
200-day EMA: 38.38 Buy

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.68 Buy
20-day SMA: 84.71 Buy
50-day SMA: 85.48 Buy
200-day SMA: 75.72 Buy
8-day EMA: 85.91 Buy
20-day EMA: 85.03 Buy
50-day EMA: 83.75 Buy
200-day EMA: 76.64 Buy

Heidrick & Struggles International Earnings Growth & HSII Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.21 per share, and an increase next year of $0.50 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $3.25 per share.

Heidrick & Struggles International Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):